NASDAQ
CervoMed Inc. (CRVO) has a free cash flow growth of -21.94% as of Friday, May 29, 2026. This represents a 428.44% decrease compared to its 12-month average of -4.15%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.